News

The study evaluated the performance of the Watchman Flx™ left atrial appendage occluder as a first-line therapy for reducing stroke risk. Research data show that the Watchman Flx™ device met all predefined primary safety endpoints and primary efficacy endpoints. At the same time, all secondary safety and efficacy endpoints were also successfully achieved. These results indicate that, as a first-line therapy, the device demonstrates excellent safety and efficacy, offering an important new option for stroke prevention.

Foresight News reports that the World Foundation tweeted that its subsidiary, World Assets, Ltd., completed OTC sales totaling $65 million with four counterparties over the past week. The first transaction will settle on March 20, 2026. The average sale price was approximately $0.2719 per token, with $25 million worth of tokens subject to a six-month lock-up period. The proceeds from this sale will be used for core operations, research and development, Orb manufacturing, and ecosystem development. The relevant settlement transactions will be processed via the World Assets multisig address starting with 0xE797.

BlockBeats News, on March 28th, Michael Saylor posted on social media stating, "It's time to put the laser eyes back on," hinting at a bullish signal.